Skip to main content
main-content
Erschienen in: Die Diabetologie 4/2022

27.04.2022 | Diabetes mellitus | Leitthema

Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz

verfasst von: Prof. Dr. med. Christian Jenssen, Dr. med. Cristine Pietsch

Erschienen in: Die Diabetologie | Ausgabe 4/2022

Einloggen, um Zugang zu erhalten

Zusammenfassung

In deutschen Krankenhäusern werden jährlich etwa 3 Mio. Patienten mit Diabetes stationär behandelt, davon 93 % nicht wegen, sondern mit dieser Erkrankung. In einzelnen Fachabteilungen liegt bei bis zu 40 % der Patienten die Nebendiagnose Diabetes vor. Sie haben oft eine relevante Komorbidität und im Vergleich zu Krankenhauspatienten ohne Diabetes eine längere stationäre Verweildauer, entwickeln deutlich häufiger Komplikationen und müssen öfter kurzfristig wieder aufgenommen werden. In dieser Übersicht wird die klinische Relevanz der Nebendiagnose Diabetes mellitus für Krankenhauspatienten besprochen.
Literatur
1.
Zurück zum Zitat Arya S, Binney ZO, Khakharia A et al (2018) High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg 67:217–228.e1 PubMedCrossRef Arya S, Binney ZO, Khakharia A et al (2018) High hemoglobin A1c associated with increased adverse limb events in peripheral arterial disease patients undergoing revascularization. J Vasc Surg 67:217–228.e1 PubMedCrossRef
3.
Zurück zum Zitat Baur DM, Klotsche J, Hamnvik OP et al (2011) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism 60:1363–1371 PubMedCrossRef Baur DM, Klotsche J, Hamnvik OP et al (2011) Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort. Metabolism 60:1363–1371 PubMedCrossRef
4.
Zurück zum Zitat Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928–1937 PubMedCrossRef Ben Q, Xu M, Ning X et al (2011) Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies. Eur J Cancer 47:1928–1937 PubMedCrossRef
5.
Zurück zum Zitat Capes SE, Hunt D, Malmberg K et al (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778 PubMedCrossRef Capes SE, Hunt D, Malmberg K et al (2000) Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773–778 PubMedCrossRef
6.
Zurück zum Zitat Chang S, Jiang J (2018) Association of body mass index and the risk of new-onset diabetes after kidney transplantation: a meta-analysis. Transplant Proc 50:1316–1325 PubMedCrossRef Chang S, Jiang J (2018) Association of body mass index and the risk of new-onset diabetes after kidney transplantation: a meta-analysis. Transplant Proc 50:1316–1325 PubMedCrossRef
7.
Zurück zum Zitat Cicek M, Buckley J, Pearson-Stuttard J et al (2021) Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches. Endocrinol Metab Clin North Am 50:531–558 PubMedPubMedCentralCrossRef Cicek M, Buckley J, Pearson-Stuttard J et al (2021) Characterizing multimorbidity from type 2 diabetes: insights from clustering approaches. Endocrinol Metab Clin North Am 50:531–558 PubMedPubMedCentralCrossRef
8.
Zurück zum Zitat Dhatariya K, Mustafa OG, Rayman G (2020) Safe care for people with diabetes in hospital. Clin Med 20:21–27 CrossRef Dhatariya K, Mustafa OG, Rayman G (2020) Safe care for people with diabetes in hospital. Clin Med 20:21–27 CrossRef
9.
Zurück zum Zitat Dreyer M, Gallwitz B, Kellerer M et al (2018) Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus, 2. Aufl. Deutsche Diabetes Gesellschaft, Berlin Dreyer M, Gallwitz B, Kellerer M et al (2018) Positionspapier der Deutschen Diabetes Gesellschaft zur Therapie des Diabetes mellitus im Krankenhaus, 2. Aufl. Deutsche Diabetes Gesellschaft, Berlin
10.
Zurück zum Zitat Eckert I, Kumbier MCC, Silva FM et al (2021) Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Clin Nutr 40:3940–3949 PubMedCrossRef Eckert I, Kumbier MCC, Silva FM et al (2021) Association of specialized enteral nutrition with glycemic control and clinical outcomes in critically ill patients: a meta-analysis of randomized controlled trials. Clin Nutr 40:3940–3949 PubMedCrossRef
11.
Zurück zum Zitat Einarson TR, Acs A, Ludwig C et al (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 17:83 PubMedPubMedCentralCrossRef Einarson TR, Acs A, Ludwig C et al (2018) Prevalence of cardiovascular disease in type 2 diabetes: a systematic literature review of scientific evidence from across the world in 2007–2017. Cardiovasc Diabetol 17:83 PubMedPubMedCentralCrossRef
12.
Zurück zum Zitat Elena JW, Steplowski E, Yu K et al (2013) Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 24:13–25 PubMedCrossRef Elena JW, Steplowski E, Yu K et al (2013) Diabetes and risk of pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium. Cancer Causes Control 24:13–25 PubMedCrossRef
13.
14.
Zurück zum Zitat Ghosal S, Datta D, Sinha B (2021) A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D). Sci Rep 11:22063 PubMedPubMedCentralCrossRef Ghosal S, Datta D, Sinha B (2021) A meta-analysis of the effects of glucagon-like-peptide 1 receptor agonist (GLP1-RA) in nonalcoholic fatty liver disease (NAFLD) with type 2 diabetes (T2D). Sci Rep 11:22063 PubMedPubMedCentralCrossRef
15.
Zurück zum Zitat Goodarzi MO, Petrov MS, Andersen DK et al (2021) Diabetes in chronic pancreatitis: risk factors and natural history. Curr Opin Gastroenterol 37:526–531 PubMedCrossRef Goodarzi MO, Petrov MS, Andersen DK et al (2021) Diabetes in chronic pancreatitis: risk factors and natural history. Curr Opin Gastroenterol 37:526–531 PubMedCrossRef
16.
Zurück zum Zitat Goodenough CJ, Liang MK, Nguyen MT et al (2015) Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg 221:854–861.e1 PubMedCrossRef Goodenough CJ, Liang MK, Nguyen MT et al (2015) Preoperative glycosylated hemoglobin and postoperative glucose together predict major complications after abdominal surgery. J Am Coll Surg 221:854–861.e1 PubMedCrossRef
17.
18.
Zurück zum Zitat Hart PA, Bellin MD, Andersen DK et al (2016) Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1:226–237 PubMedPubMedCentralCrossRef Hart PA, Bellin MD, Andersen DK et al (2016) Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 1:226–237 PubMedPubMedCentralCrossRef
19.
Zurück zum Zitat Hart PA, Bradley D, Conwell DL et al (2021) Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol 6:668–675 PubMedCrossRef Hart PA, Bradley D, Conwell DL et al (2021) Diabetes following acute pancreatitis. Lancet Gastroenterol Hepatol 6:668–675 PubMedCrossRef
20.
Zurück zum Zitat Heisel O, Heisel R, Balshaw R et al (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 4:583–595 PubMedCrossRef Heisel O, Heisel R, Balshaw R et al (2004) New onset diabetes mellitus in patients receiving calcineurin inhibitors: a systematic review and meta-analysis. Am J Transplant 4:583–595 PubMedCrossRef
21.
Zurück zum Zitat Hsiang JC, Gane EJ, Bai WW et al (2015) Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol 30:591–599 PubMedCrossRef Hsiang JC, Gane EJ, Bai WW et al (2015) Type 2 diabetes: a risk factor for liver mortality and complications in hepatitis B cirrhosis patients. J Gastroenterol Hepatol 30:591–599 PubMedCrossRef
22.
Zurück zum Zitat Hussain MA, Bin-Ayeed SA, Saeed OQ et al (2016) Impact of diabetes on carotid artery revascularization. J Vasc Surg 63:1099–1107.e4 PubMedCrossRef Hussain MA, Bin-Ayeed SA, Saeed OQ et al (2016) Impact of diabetes on carotid artery revascularization. J Vasc Surg 63:1099–1107.e4 PubMedCrossRef
23.
Zurück zum Zitat Jones CE, Graham LA, Morris MS et al (2017) Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg 152:1031–1038 PubMedPubMedCentralCrossRef Jones CE, Graham LA, Morris MS et al (2017) Association between preoperative hemoglobin A1c levels, postoperative hyperglycemia, and readmissions following gastrointestinal surgery. JAMA Surg 152:1031–1038 PubMedPubMedCentralCrossRef
24.
Zurück zum Zitat Karimian N, Niculiseanu P, Amar-Zifkin A et al (2018) Association of elevated pre-operative hemoglobin A1c and post-operative complications in non-diabetic patients: a systematic review. World J Surg 42:61–72 PubMedCrossRef Karimian N, Niculiseanu P, Amar-Zifkin A et al (2018) Association of elevated pre-operative hemoglobin A1c and post-operative complications in non-diabetic patients: a systematic review. World J Surg 42:61–72 PubMedCrossRef
25.
Zurück zum Zitat Kellerer M, Stalla G, Hrabé De Angelis M (2020) Ausbildungskapazitäten im Bereich Diabetologie und Endokrinologie müssen ausgebaut werden. In: Kellerer M, Bitzer B, Kröger J, Mattig-Fabian N (Hrsg) Deutscher Gesundheitsbericht Diabetes 2021. Die Bestandsaufnahme. Kirchheim, Mainz, S 225–230 Kellerer M, Stalla G, Hrabé De Angelis M (2020) Ausbildungskapazitäten im Bereich Diabetologie und Endokrinologie müssen ausgebaut werden. In: Kellerer M, Bitzer B, Kröger J, Mattig-Fabian N (Hrsg) Deutscher Gesundheitsbericht Diabetes 2021. Die Bestandsaufnahme. Kirchheim, Mainz, S 225–230
27.
Zurück zum Zitat Kim HJ, Jung SH, Kim JJ et al (2017) New-onset diabetes mellitus after heart transplantation-incidence, risk factors and impact on clinical outcome. Circ J 81:806–814 PubMedCrossRef Kim HJ, Jung SH, Kim JJ et al (2017) New-onset diabetes mellitus after heart transplantation-incidence, risk factors and impact on clinical outcome. Circ J 81:806–814 PubMedCrossRef
28.
Zurück zum Zitat Korytkowski MT, Salata RJ, Koerbel GL et al (2009) Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 32:594–596 PubMedPubMedCentralCrossRef Korytkowski MT, Salata RJ, Koerbel GL et al (2009) Insulin therapy and glycemic control in hospitalized patients with diabetes during enteral nutrition therapy: a randomized controlled clinical trial. Diabetes Care 32:594–596 PubMedPubMedCentralCrossRef
29.
Zurück zum Zitat Kotagal M, Symons RG, Hirsch IB et al (2015) Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261:97–103 PubMedCrossRef Kotagal M, Symons RG, Hirsch IB et al (2015) Perioperative hyperglycemia and risk of adverse events among patients with and without diabetes. Ann Surg 261:97–103 PubMedCrossRef
30.
Zurück zum Zitat Kotha S, Lawendy B, Asim S et al (2021) Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: systematic review and meta-analysis. World J Transplant 11:432–442 PubMedPubMedCentralCrossRef Kotha S, Lawendy B, Asim S et al (2021) Impact of immunosuppression on incidence of post-transplant diabetes mellitus in solid organ transplant recipients: systematic review and meta-analysis. World J Transplant 11:432–442 PubMedPubMedCentralCrossRef
31.
Zurück zum Zitat Kotwal A, Cheung YM, Cromwell G et al (2021) Patient-centered diabetes care of cancer patients. Curr Diab Rep 21:62 PubMedCrossRef Kotwal A, Cheung YM, Cromwell G et al (2021) Patient-centered diabetes care of cancer patients. Curr Diab Rep 21:62 PubMedCrossRef
33.
Zurück zum Zitat Krinsley JS, Rule P, Pappy L et al (2020) The interaction of acute and chronic glycemia on the relationship of hyperglycemia, hypoglycemia, and glucose variability to mortality in the critically ill. Crit Care Med 48:1744–1751 PubMedCrossRef Krinsley JS, Rule P, Pappy L et al (2020) The interaction of acute and chronic glycemia on the relationship of hyperglycemia, hypoglycemia, and glucose variability to mortality in the critically ill. Crit Care Med 48:1744–1751 PubMedCrossRef
34.
Zurück zum Zitat Kufeldt J, Kovarova M, Adolph M et al (2018) Prevalence and distribution of diabetes mellitus in a maximum care hospital: urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes 126:123–129 PubMedCrossRef Kufeldt J, Kovarova M, Adolph M et al (2018) Prevalence and distribution of diabetes mellitus in a maximum care hospital: urgent need for HbA1c-screening. Exp Clin Endocrinol Diabetes 126:123–129 PubMedCrossRef
35.
Zurück zum Zitat Kuhl J, Sartipy U, Eliasson B et al (2016) Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. Int J Cardiol 202:291–296 PubMedCrossRef Kuhl J, Sartipy U, Eliasson B et al (2016) Relationship between preoperative hemoglobin A1c levels and long-term mortality after coronary artery bypass grafting in patients with type 2 diabetes mellitus. Int J Cardiol 202:291–296 PubMedCrossRef
36.
Zurück zum Zitat Kwon S, Thompson R, Dellinger P et al (2013) Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:8–14 PubMedCrossRef Kwon S, Thompson R, Dellinger P et al (2013) Importance of perioperative glycemic control in general surgery: a report from the surgical care and outcomes assessment program. Ann Surg 257:8–14 PubMedCrossRef
37.
Zurück zum Zitat Lawendy B, Srinathan S, Kotha S et al (2021) Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients. Clin Transplant 35:e14340 PubMedCrossRef Lawendy B, Srinathan S, Kotha S et al (2021) Systematic review and meta-analysis of post-transplant diabetes mellitus in liver transplant recipients. Clin Transplant 35:e14340 PubMedCrossRef
38.
Zurück zum Zitat Li DW, Lu TF, Hua XW et al (2015) Risk factors for new onset diabetes mellitus after liver transplantation: a meta-analysis. World J Gastroenterol 21:6329–6340 PubMedPubMedCentralCrossRef Li DW, Lu TF, Hua XW et al (2015) Risk factors for new onset diabetes mellitus after liver transplantation: a meta-analysis. World J Gastroenterol 21:6329–6340 PubMedPubMedCentralCrossRef
39.
Zurück zum Zitat Lin LY, Lin HC, Lee PC et al (2007) Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 333:261–265 PubMedCrossRef Lin LY, Lin HC, Lee PC et al (2007) Hyperglycemia correlates with outcomes in patients receiving total parenteral nutrition. Am J Med Sci 333:261–265 PubMedCrossRef
40.
Zurück zum Zitat Lin S, He W, Zeng M (2020) Association of diabetes and admission blood glucose levels with short-term outcomes in patients with critical illnesses. J Inflamm Res 13:1151–1166 PubMedPubMedCentralCrossRef Lin S, He W, Zeng M (2020) Association of diabetes and admission blood glucose levels with short-term outcomes in patients with critical illnesses. J Inflamm Res 13:1151–1166 PubMedPubMedCentralCrossRef
41.
Zurück zum Zitat Liu XX, Zhu XM, Miao Q et al (2014) Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 65:324–332 PubMedCrossRef Liu XX, Zhu XM, Miao Q et al (2014) Hyperglycemia induced by glucocorticoids in nondiabetic patients: a meta-analysis. Ann Nutr Metab 65:324–332 PubMedCrossRef
42.
Zurück zum Zitat Luijks H, Schermer T, Bor H et al (2012) Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 10:128 PubMedPubMedCentralCrossRef Luijks H, Schermer T, Bor H et al (2012) Prevalence and incidence density rates of chronic comorbidity in type 2 diabetes patients: an exploratory cohort study. BMC Med 10:128 PubMedPubMedCentralCrossRef
43.
Zurück zum Zitat Mantovani A, Byrne CD, Targher G (2022) Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide‑1 receptor agonists, or sodium-glucose cotransporter‑2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review. Lancet Gastroenterol Hepatol 7:367–378 PubMedCrossRef Mantovani A, Byrne CD, Targher G (2022) Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide‑1 receptor agonists, or sodium-glucose cotransporter‑2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review. Lancet Gastroenterol Hepatol 7:367–378 PubMedCrossRef
45.
Zurück zum Zitat Mantovani A, Petracca G, Beatrice G et al (2021) Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70:962–969 PubMedCrossRef Mantovani A, Petracca G, Beatrice G et al (2021) Non-alcoholic fatty liver disease and risk of incident diabetes mellitus: an updated meta-analysis of 501 022 adult individuals. Gut 70:962–969 PubMedCrossRef
46.
Zurück zum Zitat Martin ET, Kaye KS, Knott C et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99 PubMedCrossRef Martin ET, Kaye KS, Knott C et al (2016) Diabetes and risk of surgical site infection: a systematic review and meta-analysis. Infect Control Hosp Epidemiol 37:88–99 PubMedCrossRef
47.
Zurück zum Zitat Maxwell DW, Jajja MR, Galindo RJ et al (2020) Post-pancreatectomy diabetes index: a validated score predicting diabetes development after major pancreatectomy. J Am Coll Surg 230:393–402.e3 PubMedCrossRef Maxwell DW, Jajja MR, Galindo RJ et al (2020) Post-pancreatectomy diabetes index: a validated score predicting diabetes development after major pancreatectomy. J Am Coll Surg 230:393–402.e3 PubMedCrossRef
48.
Zurück zum Zitat Mcalister FA, Majumdar SR, Blitz S et al (2005) The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28:810–815 PubMedCrossRef Mcalister FA, Majumdar SR, Blitz S et al (2005) The relation between hyperglycemia and outcomes in 2,471 patients admitted to the hospital with community-acquired pneumonia. Diabetes Care 28:810–815 PubMedCrossRef
49.
Zurück zum Zitat Miko A, Farkas N, Garami A et al (2018) Preexisting diabetes elevates risk of local and systemic complications in acute pancreatitis: systematic review and meta-analysis. Pancreas 47:917–923 PubMedPubMedCentralCrossRef Miko A, Farkas N, Garami A et al (2018) Preexisting diabetes elevates risk of local and systemic complications in acute pancreatitis: systematic review and meta-analysis. Pancreas 47:917–923 PubMedPubMedCentralCrossRef
50.
Zurück zum Zitat Muller-Wieland D, Merkel M, Hamann A et al (2018) Survey to estimate the prevalence of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c measurement upon admission. Int J Clin Pract 72:e13273 PubMedCrossRef Muller-Wieland D, Merkel M, Hamann A et al (2018) Survey to estimate the prevalence of type 2 diabetes mellitus in hospital patients in Germany by systematic HbA1c measurement upon admission. Int J Clin Pract 72:e13273 PubMedCrossRef
51.
Zurück zum Zitat Neu A, Kröger J (2021) Deutscher Gesundheitsbericht Diabetes 2022. Die Bestandsaufnahme. Verlag Kirchheim + Co, Mainz Neu A, Kröger J (2021) Deutscher Gesundheitsbericht Diabetes 2022. Die Bestandsaufnahme. Verlag Kirchheim + Co, Mainz
52.
Zurück zum Zitat Ojo O, Brooke J (2014) Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients 6:5142–5152 PubMedPubMedCentralCrossRef Ojo O, Brooke J (2014) Evaluation of the role of enteral nutrition in managing patients with diabetes: a systematic review. Nutrients 6:5142–5152 PubMedPubMedCentralCrossRef
53.
Zurück zum Zitat Olariu E, Pooley N, Danel A et al (2018) A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS ONE 13:e194952 PubMedPubMedCentralCrossRef Olariu E, Pooley N, Danel A et al (2018) A systematic scoping review on the consequences of stress-related hyperglycaemia. PLoS ONE 13:e194952 PubMedPubMedCentralCrossRef
55.
Zurück zum Zitat Park J, Oh AR, Lee SH et al (2021) Associations between preoperative glucose and hemoglobin A1c level and myocardial injury after noncardiac surgery. J Am Heart Assoc 10:e19216 PubMedPubMedCentralCrossRef Park J, Oh AR, Lee SH et al (2021) Associations between preoperative glucose and hemoglobin A1c level and myocardial injury after noncardiac surgery. J Am Heart Assoc 10:e19216 PubMedPubMedCentralCrossRef
56.
Zurück zum Zitat Pearson-Stuttard J, Buckley J, Cicek M et al (2021) The changing nature of mortality and morbidity in patients with diabetes. Endocrinol Metab Clin North Am 50:357–368 PubMedCrossRef Pearson-Stuttard J, Buckley J, Cicek M et al (2021) The changing nature of mortality and morbidity in patients with diabetes. Endocrinol Metab Clin North Am 50:357–368 PubMedCrossRef
57.
Zurück zum Zitat Petrov MS (2021) DIAGNOSIS OF ENDOCRINE DISEASE: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol 184:R137–R149 PubMedCrossRef Petrov MS (2021) DIAGNOSIS OF ENDOCRINE DISEASE: post-pancreatitis diabetes mellitus: prime time for secondary disease. Eur J Endocrinol 184:R137–R149 PubMedCrossRef
58.
Zurück zum Zitat Piette JD, Kerr EA (2006) The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29:725–731 PubMedCrossRef Piette JD, Kerr EA (2006) The impact of comorbid chronic conditions on diabetes care. Diabetes Care 29:725–731 PubMedCrossRef
59.
Zurück zum Zitat Richardson A, Park WG (2021) Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med 36:15–24 PubMedCrossRef Richardson A, Park WG (2021) Acute pancreatitis and diabetes mellitus: a review. Korean J Intern Med 36:15–24 PubMedCrossRef
61.
Zurück zum Zitat Safieddine B, Sperlich S, Epping J et al (2021) Development of comorbidities in type 2 diabetes between 2005 and 2017 using German claims data. Sci Rep 11:11149 PubMedPubMedCentralCrossRef Safieddine B, Sperlich S, Epping J et al (2021) Development of comorbidities in type 2 diabetes between 2005 and 2017 using German claims data. Sci Rep 11:11149 PubMedPubMedCentralCrossRef
63.
Zurück zum Zitat Singh AK, Singh R (2020) Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract 167:108382 PubMedPubMedCentralCrossRef Singh AK, Singh R (2020) Hyperglycemia without diabetes and new-onset diabetes are both associated with poorer outcomes in COVID-19. Diabetes Res Clin Pract 167:108382 PubMedPubMedCentralCrossRef
64.
Zurück zum Zitat Stepanova M, Clement S, Wong R et al (2017) Patients with diabetes and chronic liver disease are at increased risk for overall mortality: a population study from the United States. Clin Diabetes 35:79–83 PubMedPubMedCentralCrossRef Stepanova M, Clement S, Wong R et al (2017) Patients with diabetes and chronic liver disease are at increased risk for overall mortality: a population study from the United States. Clin Diabetes 35:79–83 PubMedPubMedCentralCrossRef
65.
66.
Zurück zum Zitat Tamayo T, Brinks R, Hoyer A et al (2016) The prevalence and incidence of diabetes in Germany. Dtsch Arztebl Int 113:177–182 PubMedPubMedCentral Tamayo T, Brinks R, Hoyer A et al (2016) The prevalence and incidence of diabetes in Germany. Dtsch Arztebl Int 113:177–182 PubMedPubMedCentral
67.
Zurück zum Zitat Tan DJH, Yaow CYL, Mok HT et al (2021) The influence of diabetes on postoperative complications following colorectal surgery. Tech Coloproctol 25:267–278 PubMedPubMedCentralCrossRef Tan DJH, Yaow CYL, Mok HT et al (2021) The influence of diabetes on postoperative complications following colorectal surgery. Tech Coloproctol 25:267–278 PubMedPubMedCentralCrossRef
68.
Zurück zum Zitat Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720–1732 PubMedCrossRef Tancredi M, Rosengren A, Svensson AM et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720–1732 PubMedCrossRef
69.
Zurück zum Zitat Tsilidis KK, Kasimis JC, Lopez DS et al (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607 PubMedCrossRef Tsilidis KK, Kasimis JC, Lopez DS et al (2015) Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies. BMJ 350:g7607 PubMedCrossRef
70.
Zurück zum Zitat van den Boom W, Schroeder RA, Manning MW et al (2018) Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care 41:782–788 PubMedCrossRef van den Boom W, Schroeder RA, Manning MW et al (2018) Effect of A1C and glucose on postoperative mortality in noncardiac and cardiac surgeries. Diabetes Care 41:782–788 PubMedCrossRef
71.
Zurück zum Zitat Vennard KC, Selen DJ, Gilbert MP (2018) The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition. Endocr Pract 24:900–906 PubMedCrossRef Vennard KC, Selen DJ, Gilbert MP (2018) The management of hyperglycemia in noncritically ill hospitalized patients treated with continuous enteral or parenteral nutrition. Endocr Pract 24:900–906 PubMedCrossRef
72.
Zurück zum Zitat Wan G, Sun X, Li F et al (2018) Survival benefit of metformin adjuvant treatment for pancreatic cancer patients: a systematic review and meta-analysis. Cell Physiol Biochem 49:837–847 PubMedCrossRef Wan G, Sun X, Li F et al (2018) Survival benefit of metformin adjuvant treatment for pancreatic cancer patients: a systematic review and meta-analysis. Cell Physiol Biochem 49:837–847 PubMedCrossRef
73.
Zurück zum Zitat Wang W, Chen W, Liu Y et al (2021) Blood glucose levels and mortality in patients with sepsis: dose-response analysis of observational studies. J Intensive Care Med 36:182–190 PubMedCrossRef Wang W, Chen W, Liu Y et al (2021) Blood glucose levels and mortality in patients with sepsis: dose-response analysis of observational studies. J Intensive Care Med 36:182–190 PubMedCrossRef
74.
Zurück zum Zitat Wild SH, Walker JJ, Morling JR et al (2018) Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41:341–347 PubMedCrossRef Wild SH, Walker JJ, Morling JR et al (2018) Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission. Diabetes Care 41:341–347 PubMedCrossRef
75.
Zurück zum Zitat Wojciechowska J, Krajewski W, Bolanowski M et al (2016) Diabetes and cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes 124:263–275 PubMedCrossRef Wojciechowska J, Krajewski W, Bolanowski M et al (2016) Diabetes and cancer: a review of current knowledge. Exp Clin Endocrinol Diabetes 124:263–275 PubMedCrossRef
76.
Zurück zum Zitat Worley N, Buza J, Jalai CM et al (2017) Diabetes as an independent predictor for extended length of hospital stay and increased adverse post-operative events in patients treated surgically for cervical spondylotic myelopathy. Int J Spine Surg 11:10 PubMedPubMedCentralCrossRef Worley N, Buza J, Jalai CM et al (2017) Diabetes as an independent predictor for extended length of hospital stay and increased adverse post-operative events in patients treated surgically for cervical spondylotic myelopathy. Int J Spine Surg 11:10 PubMedPubMedCentralCrossRef
78.
Zurück zum Zitat Wu L, Nahm CB, Jamieson NB et al (2020) Risk factors for development of diabetes mellitus (type 3c) after partial pancreatectomy: a systematic review. Clin Endocrinol (Oxf) 92:396–406 CrossRef Wu L, Nahm CB, Jamieson NB et al (2020) Risk factors for development of diabetes mellitus (type 3c) after partial pancreatectomy: a systematic review. Clin Endocrinol (Oxf) 92:396–406 CrossRef
79.
Zurück zum Zitat Wu L, Zhu J, Prokop LJ et al (2015) Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies. Sci Rep 5:10147 PubMedPubMedCentralCrossRef Wu L, Zhu J, Prokop LJ et al (2015) Pharmacologic therapy of diabetes and overall cancer risk and mortality: a meta-analysis of 265 studies. Sci Rep 5:10147 PubMedPubMedCentralCrossRef
80.
Zurück zum Zitat Xia M, Yang H, Tong X et al (2021) Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J Diabetes Investig 12:109–122 PubMedCrossRef Xia M, Yang H, Tong X et al (2021) Risk factors for new-onset diabetes mellitus after kidney transplantation: a systematic review and meta-analysis. J Diabetes Investig 12:109–122 PubMedCrossRef
81.
Zurück zum Zitat Xu H, Zhang L, Kang H et al (2021) Metabolomics identifies biomarker signatures to differentiate pancreatic cancer from type 2 diabetes mellitus in early diagnosis. Int J Endocrinol 2021:9990768 PubMedPubMedCentralCrossRef Xu H, Zhang L, Kang H et al (2021) Metabolomics identifies biomarker signatures to differentiate pancreatic cancer from type 2 diabetes mellitus in early diagnosis. Int J Endocrinol 2021:9990768 PubMedPubMedCentralCrossRef
82.
Zurück zum Zitat Yao S, Li J, Fan X et al (2018) The effect of selective serotonin re-uptake inhibitors on risk of type II diabetes mellitus and acute pancreatitis: a meta-analysis. Biosci Rep 38(5):BSR20180967 PubMedPubMedCentralCrossRef Yao S, Li J, Fan X et al (2018) The effect of selective serotonin re-uptake inhibitors on risk of type II diabetes mellitus and acute pancreatitis: a meta-analysis. Biosci Rep 38(5):BSR20180967 PubMedPubMedCentralCrossRef
83.
84.
Zurück zum Zitat Yin M, Zhou J, Gorak EJ et al (2013) Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18:1248–1255 PubMedPubMedCentralCrossRef Yin M, Zhou J, Gorak EJ et al (2013) Metformin is associated with survival benefit in cancer patients with concurrent type 2 diabetes: a systematic review and meta-analysis. Oncologist 18:1248–1255 PubMedPubMedCentralCrossRef
85.
Zurück zum Zitat Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71:793–801 PubMedCrossRef Younossi ZM, Golabi P, de Avila L et al (2019) The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis. J Hepatol 71:793–801 PubMedCrossRef
86.
Zurück zum Zitat Yu J, Sun R, Han X et al (2020) New-onset diabetes mellitus after distal pancreatectomy: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 30:1215–1222 PubMedCrossRef Yu J, Sun R, Han X et al (2020) New-onset diabetes mellitus after distal pancreatectomy: a systematic review and meta-analysis. J Laparoendosc Adv Surg Tech A 30:1215–1222 PubMedCrossRef
87.
Zurück zum Zitat Zghebi SS, Steinke DT, Rutter MK et al (2020) Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open 10:e33866 PubMedCrossRef Zghebi SS, Steinke DT, Rutter MK et al (2020) Eleven-year multimorbidity burden among 637 255 people with and without type 2 diabetes: a population-based study using primary care and linked hospitalisation data. BMJ Open 10:e33866 PubMedCrossRef
88.
Zurück zum Zitat Zhang J, Ma J, Guo L et al (2020) Survival benefit of metformin use for pancreatic cancer patients who underwent pancreatectomy: results from a meta-analysis. Front Med (Lausanne) 7:282 CrossRef Zhang J, Ma J, Guo L et al (2020) Survival benefit of metformin use for pancreatic cancer patients who underwent pancreatectomy: results from a meta-analysis. Front Med (Lausanne) 7:282 CrossRef
89.
Zurück zum Zitat Zhao Y, Xing H, Wang X et al (2019) Management of diabetes mellitus in patients with chronic liver diseases. J Diabetes Res 2019:6430486 PubMedPubMedCentral Zhao Y, Xing H, Wang X et al (2019) Management of diabetes mellitus in patients with chronic liver diseases. J Diabetes Res 2019:6430486 PubMedPubMedCentral
90.
Zurück zum Zitat Zhi M, Zhu X, Lugea A et al (2019) Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol 10:637 PubMedPubMedCentralCrossRef Zhi M, Zhu X, Lugea A et al (2019) Incidence of new onset diabetes mellitus secondary to acute pancreatitis: a systematic review and meta-analysis. Front Physiol 10:637 PubMedPubMedCentralCrossRef
91.
Zurück zum Zitat Zhou PT, Li B, Liu FR et al (2017) Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget 8:25242–25250 PubMedPubMedCentralCrossRef Zhou PT, Li B, Liu FR et al (2017) Metformin is associated with survival benefit in pancreatic cancer patients with diabetes: a systematic review and meta-analysis. Oncotarget 8:25242–25250 PubMedPubMedCentralCrossRef
92.
Zurück zum Zitat Zhu X, Liu D, Wei Q et al (2019) New-onset diabetes mellitus after chronic pancreatitis diagnosis: a systematic review and meta-analysis. Pancreas 48:868–875 PubMedCrossRef Zhu X, Liu D, Wei Q et al (2019) New-onset diabetes mellitus after chronic pancreatitis diagnosis: a systematic review and meta-analysis. Pancreas 48:868–875 PubMedCrossRef
Metadaten
Titel
Stationäre Patienten mit der Nebendiagnose Diabetes mellitus: klinische Relevanz
verfasst von
Prof. Dr. med. Christian Jenssen
Dr. med. Cristine Pietsch
Publikationsdatum
27.04.2022
Verlag
Springer Medizin
Erschienen in
Die Diabetologie / Ausgabe 4/2022
Print ISSN: 2731-7447
Elektronische ISSN: 2731-7455
DOI
https://doi.org/10.1007/s11428-022-00897-2

Weitere Artikel der Ausgabe 4/2022

Die Diabetologie 4/2022 Zur Ausgabe

Einführung zum Thema

Diabetes im Krankenhaus

Neu im Fachgebiet Innere Medizin

Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Innere Medizin und bleiben Sie gut informiert – ganz bequem per eMail.